about
Designing modulators of monoamine transporters using virtual screening techniquesThe Cryptosporidium parvum KinomeCharacterization of a UBC13 kinase in Plasmodium falciparumMachine learning methods for prediction of CDK-inhibitorsIncreased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanismExpanding the Antimalarial Drug Arsenal-Now, But How?Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials.3-bromohomofascaplysin A, a fascaplysin analogue from a Fijian Didemnum sp. ascidianCorrelation between Cyclin Dependent Kinases and Artemisinin-Induced Dormancy in Plasmodium falciparum In Vitro.Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.Antimalarial drug discovery: targeting protein kinases.Novel molecular targets for antimalarial drug development.Unraveling the biology of a fungal meningitis pathogen using chemical genetics.Retrieval of Enterobacteriaceae drug targets using singular value decomposition.QSAR analysis of benzophenone derivatives as antimalarial agents.Antiplasmodial activity of steroidal chalcones: evaluation of their effect on hemozoin synthesis and the new permeation pathway of Plasmodium falciparum-infected erythrocyte membrane.A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis.Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro.
P2860
Q26781605-8B2D1687-DF3D-4281-A01C-275D6AF00B34Q27674622-4C65A339-0541-403E-A54B-807AEAEBB437Q27976461-D315138C-4CAF-4E77-8481-AE5A5EF811D2Q28475771-777AE921-9BDF-4282-A68F-E083E6810828Q33826319-05526A5C-120A-4474-B6C4-99377E2C63EEQ33916111-ECF2425A-7CDE-48B2-AAEA-F1CD142754CCQ35091523-CB8FE850-42A2-4D35-812F-044D309136A8Q35489580-A0CB988D-89C8-4529-85DE-1E0F21BCD8ABQ36057571-375A9836-B651-48EE-A1FB-864A9BE51C88Q36558336-291FC869-FCDA-49CC-887B-58DA4FA1AC3BQ36734919-E6F6B3D4-01EB-4641-B157-01E881264630Q37093960-32879CC7-F1E3-4A63-9F9B-CB03A0B603CDQ41652452-9D3705CB-1149-4ADF-B5A9-EC8F0D72213BQ41722339-570AF23E-0164-4E48-9E37-5A2A8E781608Q42124833-1B30EFA4-76E3-401F-AD27-D51249F5A469Q42722365-04E4F5DA-9642-4431-86EA-B7FFB02DF018Q46960529-56D46A5A-07FA-4711-A7F1-ADE0F9B5AEE6Q53540561-D0A155EF-9084-4A9C-A8A2-0F41E9DCE3E8
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Targeting malaria with specific CDK inhibitors.
@ast
Targeting malaria with specific CDK inhibitors.
@en
type
label
Targeting malaria with specific CDK inhibitors.
@ast
Targeting malaria with specific CDK inhibitors.
@en
prefLabel
Targeting malaria with specific CDK inhibitors.
@ast
Targeting malaria with specific CDK inhibitors.
@en
P1476
Targeting malaria with specific CDK inhibitors
@en
P2093
Jeanne A Geyer
Norman C Waters
P304
P356
10.1016/J.BBAPAP.2005.07.031
P407
P577
2005-09-09T00:00:00Z